An experimental drug can help patients with advanced multiple sclerosis delay the progressive disability that comes with their disorder, a new clinical trial suggests. The drug, tolebrutinib, delayed ...
JOE SHAPIRO, INVESTIGATIONS, NPR: My name is Joe Shapiro. I'm a correspondent at NPR. I work on the Investigations unit, but I've had a long interest in disability issues. I've been writing about this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results